Home
Conditions
Melanoma

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,209 public trials 376 recruiting studies

Refine in advanced search Browse all conditions

Melanoma trial results

Completed

Safety and Efficacy of AK104, a PD-1/CTLA-4 Bispecific Antibody, in Selected Advanced Solid Tumors

NCT04172454

Conditions: Advanced Solid Tumors, Melanoma, Neoplasms, +10 more
Locations: Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Completed

Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma

NCT00679289

Conditions: Cutaneous Melanoma, Melanoma, Metastatic Melanoma, +11 more
Locations: University of Chicago Hospital Chicago, Illinois, United States

University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)

NCT00142454

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: NYU Cancer Institute New York, United States

View Trial Details

Completed

Avadomide (CC-122) in Combination With Nivolumab in Advanced Melanoma

NCT03834623

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas

NCT04551352

Conditions: Cutaneous Melanoma, Eye Diseases, Eye Neoplasms, +16 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

Memorial Sloan-Kettering Cancer Center New York, United States

Thomas Jefferson University Hospital;Medical Oncology Philadelphia, Pennsylvania, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

View all 14 locations

View Trial Details

Completed

Modifying Young Adult Skin Cancer Risk and Protective Behaviors

NCT03313492

Conditions: Melanoma, Melanoma and Other Malignant Neoplasms of Skin, Neoplasms, +10 more
Locations: Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

NCT03241173

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +74 more
Locations: The University of Alabama Birmingham (UAB) Birmingham, Alabama, United States

Scottsdale Healthcare Hospitals DBA HonorHealth Scottsdale, Arizona, United States

The Angeles Clinic and Research Institute Los Angeles, California, United States

Mount Sinai Medical Center of Florida, Inc. Miami, Florida, United States

View all 15 locations

View Trial Details

Completed

A Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma Recurrence

NCT02334735

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: New York University Langone Medical Center New York, United States

Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Completed

Safety and Tolerability of Pembrolizumab (MK-3475) + Pegylated Interferon Alfa-2b and Pembrolizumab+ Ipilimumab in Participants With Advanced Melanoma or Renal Cell Carcinoma (MK-3475-029/KEYNOTE-29)

NCT02089685

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +23 more
Locations: Not specified

View Trial Details

Completed

Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy

NCT02307500

Conditions: Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, +39 more
Locations: Istituto Clinico Humanitas Rozzano, Milan, Italy

View Trial Details

Melanoma

Melanoma trial results

Related conditions